MLchartDataset catalogue

Mirivadelgat

Term · Oncology and biomedicine · MLC-T-ONC-015200

An orally bioavailable selective activator of the mitochondrial isoform of aldehyde dehydrogenase (ALDH2), with potential protective activity. Upon oral administration, mirivadelgat increases ALDH2 activity. This increases the metabolism of toxic reactive aldehydes and lowers the level of the toxic aldehydes. This may protect cells from the toxic aldehydes and prevent mitochondria diseases and disorders. ALDH2, a mitochondrial regulator of toxic aldehyde metabolism, plays an important role in the metabolism of toxic aldehydes. Toxic aldehydes are produced by oxidative stress.

Table 1. Record
IdentifierMLC-T-ONC-015200
FieldOncology and biomedicine
Synonymsaldehyde dehydrogenase 2 activator FP-045; ALDH2 activator FP-045
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015200",
  "term": "Mirivadelgat",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable selective activator of the mitochondrial isoform of aldehyde dehydrogenase (ALDH2), with potential protective activity. Upon oral administration, mirivadelgat increases ALDH2 activity. This increases the metabolism of toxic reactive aldehydes and lowers the level of the toxic aldehydes. This may protect cells from the toxic aldehydes and prevent mitochondria diseases and disorders. ALDH2, a mitochondrial regulator of toxic aldehyde metabolism, plays an important role in the metabolism of toxic aldehydes. Toxic aldehydes are produced by oxidative stress.",
  "synonyms": [
    "aldehyde dehydrogenase 2 activator FP-045",
    "ALDH2 activator FP-045"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/mirivadelgat/"
}

Record 11,088 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.